Cubist(CBST) is up 5% today on heavy volume of  1.2M shares on no apparent news.52 week high is $25.48.On Monday the stock was $21.5.

Maybe there is news on the TEVA lawsuit. CBST has a compelling valuation with ~$900M in cash and forecasted revenues of $688M, EPS of 34c/sh. with a market cap of $1.45B  .

It is one of Jeffries’ Top Picks in healthcare with a target of $29.

Cubist Pharmaceuticals: Lots of Cash and Low Valuation – Seeking Alpha

Chart forCubist Pharmaceuticals Inc. (CBST)

Other upside big movers in the Model Portfolio are:

Regeneron(REGN $39.93) up 3%, Supergen(SUPG $2.90) up 4%, Viropharma (VPHM $19.38) up 7.8%.

Value and acquisition play Cephalon(CEPH $57.65) is up 0.8%.

%d bloggers like this: